Literature DB >> 25481051

Biological functions of hyaluronan and cytokine-inducible deubiquitinating enzymes.

Suresh Ramakrishna1, Bharathi Suresh1, Kwang-Hyun Baek2.   

Abstract

The modification of proteins through post-translation and degradation by the ubiquitin-proteasome system plays a pivotal role in a broad array of biological processes. Reversal of this process by deubiquitination is a central step in the maintenance and regulation of cellular homeostasis. It now appears that the regulation of ubiquitin pathways by deubiquitinating enzymes (DUBs) could be used as targets for anticancer therapy. Recent success in inducing apoptosis in cancerous cells by USP17, a cytokine-inducible DUB encoding two hyaluronan binding motifs (HABMs) showing direct interaction with hyaluronan (HA), could prove a promising step in the development of DUBs containing HABMs as agents in anticancer therapeutics. In this review, we summarize the importance of hyaluronan (HA) in cancer, the role played by DUBs in apoptosis, and a possible relationship between DUBs and HA in cancerous cells, suggesting new strategies for applying DUB enzymes as potential anticancer therapeutics.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Bioconjugates; CD44; DUB enzyme; Hyaluronan; Tumor

Mesh:

Substances:

Year:  2014        PMID: 25481051     DOI: 10.1016/j.bbcan.2014.11.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint.

Authors:  Key-Hwan Lim; Myoung-Hyun Song; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2016-01-13       Impact factor: 9.261

Review 2.  The role of deubiquitinating enzymes in spermatogenesis.

Authors:  Bharathi Suresh; Junwon Lee; Seok-Ho Hong; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Cell Mol Life Sci       Date:  2015-09-08       Impact factor: 9.261

Review 3.  Regulation of pluripotency and differentiation by deubiquitinating enzymes.

Authors:  B Suresh; J Lee; H Kim; S Ramakrishna
Journal:  Cell Death Differ       Date:  2016-06-10       Impact factor: 15.828

4.  Steady-state kinetic studies reveal that the anti-cancer target Ubiquitin-Specific Protease 17 (USP17) is a highly efficient deubiquitinating enzyme.

Authors:  Nicole M Hjortland; Andrew D Mesecar
Journal:  Arch Biochem Biophys       Date:  2016-10-15       Impact factor: 4.013

5.  A Multifaceted Role for Myd88-Dependent Signaling in Progression of Murine Mammary Carcinoma.

Authors:  Mary J Higgins; Antonio Serrano; Kofi Y Boateng; Victoria A Parsons; Tiffany Phuong; Alyssa Seifert; Jacob M Ricca; Kyle C Tucker; Alec S Eidelman; Maureen A Carey; Robert A Kurt
Journal:  Breast Cancer (Auckl)       Date:  2016-10-27

6.  The deubiquitinating enzymes USP4 and USP17 target hyaluronan synthase 2 and differentially affect its function.

Authors:  M Mehić; V K de Sa; S Hebestreit; C-H Heldin; P Heldin
Journal:  Oncogenesis       Date:  2017-06-12       Impact factor: 7.485

Review 7.  The Importance of Ubiquitination and Deubiquitination in Cellular Reprogramming.

Authors:  Bharathi Suresh; Junwon Lee; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Stem Cells Int       Date:  2016-01-06       Impact factor: 5.443

8.  Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases.

Authors:  Seemana Bhattacharya; Dipankar Chakraborty; Malini Basu; Mrinal K Ghosh
Journal:  Signal Transduct Target Ther       Date:  2018-06-29

9.  USP17 mediates macrophage-promoted inflammation and stemness in lung cancer cells by regulating TRAF2/TRAF3 complex formation.

Authors:  Chih-Hao Lu; Da-Wei Yeh; Chao-Yang Lai; Yi-Ling Liu; Li-Rung Huang; Alan Yueh-Luen Lee; S-L Catherine Jin; Tsung-Hsien Chuang
Journal:  Oncogene       Date:  2018-07-23       Impact factor: 9.867

10.  The efficacy of rhBMP-2 loaded hydrogel composite on bone formation around dental implants in mandible bone defects of minipigs.

Authors:  Hao-Zhen Lyu; Jae Hyup Lee
Journal:  Biomater Res       Date:  2020-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.